Aurora Cannabis Inc. ($ACB) Stock Forecast: Up 5.1% Today

What is Aurora Cannabis Inc.?

Asset Aurora Cannabis Inc. (ACB) is a company operating in the global medical cannabis market, with a commitment to fostering diversity and empowering women in leadership positions. The stock has recently shown volatility in line with broader market movements.

Why is Aurora Cannabis Inc. going up?

ACB stock is up 5.1% on Mar 31, 2026 18:11

• The bullish movement in Aurora Cannabis Inc. (ACB) today could be attributed to:
• The company's recognition for gender diversity on its leadership team, highlighting its commitment to inclusivity and talent development.
• Positive financial performance, potentially indicated by strong cash from operating activities, which may have instilled confidence in investors.
• Despite recent market downturns, Aurora Cannabis Inc. managed to outperform the broader market, showcasing resilience and potential strength in its operations.
• The consecutive days of stock increases could be a result of strategic decisions or market sentiment favoring the company's position in the medical cannabis industry.

ACB Price Chart

ACB Technical Analysis

ACB News

Aurora Cannabis (NASDAQ: ACB) earns Women Lead Here recognition again

Aurora Cannabis Inc. has been named to The Globe and Mail’s 2026 Women Lead Here list for the second consecutive year, recognizing its strong executive-level gender diversity with 50% female representation on its leadership team. This achievement underscores Aurora's commitment to fostering an inclusive culture and developing diverse female talent. The company emphasizes that this recognition aligns with its dedication to empowering women in leadership and creating positive outcomes for its global medical cannabis markets, patients, and communities.

https://www.stocktitan.net/sec-filings/ACB/6-k-aurora-cannabis-inc-current-report-foreign-issuer-dbe3c39f1f10.html

Cash from operating activities of Aurora Cannabis Inc. – BSESOF:21P

This article presents financial data for Aurora Cannabis Inc. (BSESOF:21P), specifically focusing on its cash from operating activities. It provides an overview of the company's financial performance within the context of the Bulgarian stock market, as found on TradingView. The page reiterates the company's stock symbol and market status in the header.

https://www.tradingview.com/symbols/BSESOF-21P/financials-cash-flow/cash-f-operating-activities/

Aurora Cannabis Inc. stock falls Friday, underperforms market

Aurora Cannabis Inc.'s stock experienced a 4.19% drop on Friday, closing at $3.20. This decline occurred during a broader market downturn, with both the NASDAQ Composite Index and the Dow Jones Industrial Average also falling significantly. This marks the second consecutive day of losses for Aurora Cannabis.

https://www.marketwatch.com/data-news/aurora-cannabis-inc-stock-falls-friday-underperforms-market-6e441dda-2e732157fb7c?gaa_at=eafs&gaa_n=AWEtsqc1KG_tx4eF_2ZRnKakO_2hys4zr2hvSzDED-IUi4o8jUpj4L8iV72k&gaa_ts=69c80eb9&gaa_sig=oBgagUi0JG26DIoPhFID4dgu3h2nOjnkcSsp3rsXkCJb3Yprmo-QeivnsAIMuI6mkiylxxUIOjFjQb1J1I9x_A%3D%3D

Aurora Cannabis Inc. stock falls Thursday, still outperforms market

Aurora Cannabis Inc. (ACB) stock decreased by 2.34% on Thursday, closing at $3.34. This fall occurred during a generally difficult trading session where the NASDAQ Composite Index fell 2.38% and the Dow Jones Industrial Average fell 1.01%. Despite the decline, the stock still outperformed the overall market.

https://www.marketwatch.com/data-news/aurora-cannabis-inc-stock-falls-thursday-still-outperforms-market-19432d4c-68f86a1a6ef7?gaa_at=eafs&gaa_n=AWEtsqeKsEcvLqIpIOBp54rNiyWZJCcDqZg48tFde93_gIONigq_kC-UUR01&gaa_ts=69c60d54&gaa_sig=34dpmtKDgZiULQ67SaHZPrrWZ7jqDrdc-qFSgDql3QYukh2k9ENpnJCiYDsWYicvDETYb8vcgvVzMUy4qYr4sg%3D%3D

Aurora Cannabis Inc. stock rises Wednesday, outperforms market

Aurora Cannabis Inc. (ACB) saw its stock rise by 3.01% on Wednesday, closing at $3.42. This performance outpaced the broader market, as both the NASDAQ Composite Index and the Dow Jones Industrial Average also recorded gains. This marks the third consecutive day of increases for Aurora's stock.

https://www.marketwatch.com/data-news/aurora-cannabis-inc-stock-rises-wednesday-outperforms-market-804a7cf6-42d97d411a57?mod=mw_quote_news&gaa_at=eafs&gaa_n=AWEtsqfumsLTnRKIsqjZ3Xb_x3O6c3w3JO7Eo40lM9X6g-6K5gaHAlGG80rS&gaa_ts=69c60d54&gaa_sig=Oh_UP6INcvOGR077L4F1fAANAfZzl7g38v5a_Uv-i645anf_sFHRT4Vi88221caQ4yxWLI7qiCyQDdT4ZZb2RQ%3D%3D

Trending Today

Crude Oil ($CRUDE) Commodity Forecast: Down 5.3% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 6.0% Today

Heating Oil ($HEATOIL) Commodity Forecast: Down 5.0% Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Up 5.0% Today

Teradyne, Inc. ($TER) Stock Forecast: Up 8.0% Today

Blink Charging Co. ($BLNK) Stock Forecast: Up 10.9% Today

Carnival Corporation ($CCL) Stock Forecast: Up 8.2% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Up 9.5% Today

Emerson Electric Company ($EMR) Stock Forecast: Up 6.4% Today

Fortune Brands Innovations Inc. ($FBIN) Stock Forecast: Up 5.2% Today

Aurora Cannabis Inc. Price History

13.01.2026 - ACB Stock was up 5.6%

• The positive movement in ACB's stock today is linked to the company's decision to restructure its investment in Bevo Agtech, selecting preferred shares with a 5% annual dividend and additional shareholder protections. This strategic move underscores Aurora's focus on creating a more efficient capital structure and prioritizing its core cannabis operations.
• Furthermore, Aurora's upcoming participation in ringing the Nasdaq closing bell to highlight its shift towards being a medical-first, globally oriented cannabis company could have boosted investor confidence, contributing to the favorable market sentiment.
• The company's expansion of its medical cannabis portfolio in Australia and New Zealand by introducing new products derived from its unique genetics further demonstrates its dedication to global expansion and meeting the changing needs of healthcare professionals and patients. This expansion likely spurred optimism among investors about Aurora's long-term prospects in international markets, fueling the positive movement in its stock.

20.01.2026 - ACB Stock was up 6.3%

• Aurora Cannabis CFO's participation in a healthcare conference and discussion of international leadership and manufacturing trends in medical cannabis likely boosted investor confidence in the company's strategic direction.
• The completion of the Bevo transaction aimed at diversifying Aurora's portfolio and strengthening its competitive position could have positively influenced market sentiment.
• Positive analyst ratings and recommendations, along with being highlighted as one of the top investment choices in the cannabis sector, might have attracted more investors to ACB, contributing to its bullish movement.
• The overall positive outlook for Aurora Cannabis, including strong fiscal performance and debt-free status, could have further supported the bullish trend in the stock price.

05.02.2026 - ACB Stock was down 5.4%

• The recent decline in ACB's stock price may be linked to the company's shift away from lower-margin Canadian consumer markets in favor of medical cannabis operations.
• Investors are anxious about potential short-term financial effects as Aurora Cannabis makes this transition, prompting them to sell off the stock.
• Despite positive analyst outlooks and a "Buy" rating suggesting a 66% upside, market sentiment is cautious as the company undergoes this strategic change, potentially leading to stock price fluctuations.
• Targeting lucrative international medical markets such as Germany and Australia, though promising for future growth, is generating uncertainty among investors in the immediate term, contributing to the stock's recent bearish trend.

05.01.2026 - ACB Stock was down 7.2%

• Aurora Cannabis (ACB) stock faced a strong bearish movement today, dropping by 7.9% to reach a new 52-week low.
• Despite posting positive Q3 earnings, including a 7% increase in net revenue and achieving positive free cash flow, the stock declined by 7.2%. Factors contributing to this decline were anticipated Q4 one-time cash costs, an inventory write-off, and a significant decrease in consumer cannabis revenue.
• The announcement of a U.S.$100 million at-the-market share program by Aurora Cannabis may have influenced the bearish sentiment due to concerns about potential dilution and future capital requirements.
• Analysts have maintained an average "Buy" rating with a consensus price target of C$9.25 for Aurora Cannabis, despite adjusting a few targets downward. This indicates a varied sentiment in the market regarding the company's future performance.

11.01.2026 - ACB Stock was down 5.2%

• ACB posted strong Q3 fiscal 2026 results, exceeding earnings and sales expectations primarily due to its medical cannabis division, but its stock faced a downward trend.
• The launch of a US$100 million ATM equity scheme with TD Securities hints at potential share dilution ahead, likely influencing investors' pessimism.
• The company's shift towards global markets and decision to withdraw from certain Canadian consumer cannabis sectors may have sparked doubts about its growth strategy, impacting stock performance.
• Varying analyst ratings and the focus on boosting profitability through operational efficiencies have possibly created investor uncertainty, contributing to the downtrend in ACB shares.

20.02.2026 - ACB Stock was down 5.1%

• The stock of Aurora Cannabis Inc. (ACB) experienced a bearish movement today, declining by 1.98% amidst a challenging trading session for the overall market.
• The initiation of coverage on ACB with a speculative buy rating and a price target of C$10 did not seem to have a positive impact on the stock's performance.
• The previous day's rise in ACB stock price was not sustained, indicating a potential reversal in investor sentiment.
• The analysis highlighted weak near and long-term ratings, suggesting that investors may have been cautious about the stock's future performance, contributing to the bearish movement.

04.01.2026 - ACB Stock was down 8.7%

• The launch of four new websites by Aurora Cannabis Inc. showcasing its science-backed cannabis leadership in European markets did not have the desired positive impact on the stock price.
• Despite the company's continued investment and commitment to the region, investors may have been expecting more concrete developments or financial results rather than just digital initiatives.
• The lack of immediate market reaction to the website launch suggests that investors are looking for more substantial growth drivers or positive financial indicators to drive the stock price higher.
• The bearish movement in ACB's stock today could be attributed to profit-taking by traders following a period of relative stability or a broader negative sentiment in the cannabis sector.

04.01.2026 - ACB Stock was down 7.4%

• The bearish movement in ACB stock today could be attributed to profit-taking by investors after a recent positive earnings report and strategic announcements.
• The launch of a U.S.$100 million at-the-market share program may have raised concerns among investors about potential dilution of existing shares, leading to a sell-off.
• Despite the positive revenue growth and focus on the medical cannabis market, the market sentiment might have been impacted by the company's near 52-week low stock price and the perceived oversold position highlighted by analysts.
• The overall market reaction to the strategic shifts and global growth initiatives of Aurora Cannabis seems to be mixed, with investors possibly taking a cautious approach amid uncertainties surrounding the company's future profitability and capital raising activities.

25.02.2026 - ACB Stock was up 6.1%

• Aurora Cannabis Inc. (ACB) witnessed a 1.53% increase in its stock price today, breaking a previous downtrend, despite sector challenges.
• XETRA's pre-market trading indicated a 2.86% decrease, attributed to sector weaknesses and high inventory levels, highlighting the company's ongoing struggles.
• Despite recently hitting a new 52-week low, analysts maintain a "Buy" consensus with a target price of C$9.25, reflecting differing opinions on the company's future.
• The stock's performance diverged from the broader market today, showcasing better performance during a positive trading session, indicating potential volatility and uncertainty in the cannabis sector.

31.02.2026 - ACB Stock was up 5.1%

• The bullish movement in Aurora Cannabis Inc. (ACB) today could be attributed to:
• The company's recognition for gender diversity on its leadership team, highlighting its commitment to inclusivity and talent development.
• Positive financial performance, potentially indicated by strong cash from operating activities, which may have instilled confidence in investors.
• Despite recent market downturns, Aurora Cannabis Inc. managed to outperform the broader market, showcasing resilience and potential strength in its operations.
• The consecutive days of stock increases could be a result of strategic decisions or market sentiment favoring the company's position in the medical cannabis industry.

06.01.2026 - ACB Stock was up 5.0%

• Aurora Cannabis established a US$100 million ATM equity program with TD Securities to improve its financial flexibility, which has been positively viewed by investors.
• The company reported modest revenue growth in Q3 FY26. However, its strong performance in the global medical cannabis market and strategic focus on key international markets such as Germany, Australia, and Poland have garnered investor support, leading to an optimistic movement in the stock.
• Aurora's decision to exit select Canadian consumer cannabis markets and streamline operations to boost profitability has instilled confidence in investors regarding the company's future growth prospects.
• Despite the dip in Aurora Cannabis shares following the Q3 results showing modest revenue growth, the market's positive reaction to the company's strategic shift towards higher-margin medical markets and operational efficiency has resulted in a rebound in the stock price.

03.02.2026 - ACB Stock was down 5.3%

• Investors may question the growth potential of Aurora Cannabis in the recreational cannabis market as the company shifts exclusively to medical cannabis and targets regulated international markets.
• The strategic shift, including reducing focus on the Canadian consumer business and expanding GMP manufacturing, could be seen as a defensive response to industry challenges, leading to a negative sentiment among traders.
• Despite analysts predicting a potential 66.60% upside for ACB stock, doubts remain about the company's ability to leverage future market trends given concerns about its track record, net losses, and limited presence in the U.S. market.
• Market insights and trading signals suggesting a weak long-term rating for ACB:CA align with the observed bearish movement, reflecting a lack of confidence in the company's future growth prospects.